nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—CYP3A4—Temozolomide—melanoma	0.0773	0.576	CbGbCtD
Montelukast—CYP3A4—Vemurafenib—melanoma	0.0424	0.316	CbGbCtD
Montelukast—CYP3A4—Docetaxel—melanoma	0.0145	0.108	CbGbCtD
Montelukast—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.00549	0.0101	CcSEcCtD
Montelukast—Memory impairment—Temozolomide—melanoma	0.00547	0.0101	CcSEcCtD
Montelukast—Eosinophilia—Vemurafenib—melanoma	0.00522	0.0096	CcSEcCtD
Montelukast—Liver injury—Temozolomide—melanoma	0.0051	0.00939	CcSEcCtD
Montelukast—Foetor hepaticus—Docetaxel—melanoma	0.00503	0.00926	CcSEcCtD
Montelukast—Disturbance in attention—Temozolomide—melanoma	0.00495	0.00912	CcSEcCtD
Montelukast—Wheezing—Bleomycin—melanoma	0.00494	0.0091	CcSEcCtD
Montelukast—Viral infection—Temozolomide—melanoma	0.00475	0.00875	CcSEcCtD
Montelukast—Infestation—Vemurafenib—melanoma	0.0047	0.00865	CcSEcCtD
Montelukast—Infestation NOS—Vemurafenib—melanoma	0.0047	0.00865	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.00466	0.00857	CcSEcCtD
Montelukast—Neuropathy peripheral—Vemurafenib—melanoma	0.00461	0.00848	CcSEcCtD
Montelukast—Liver disorder—Docetaxel—melanoma	0.00419	0.00771	CcSEcCtD
Montelukast—Neuropathy—Carmustine—melanoma	0.00417	0.00768	CcSEcCtD
Montelukast—Connective tissue disorder—Vemurafenib—melanoma	0.00414	0.00763	CcSEcCtD
Montelukast—Disorientation—Bleomycin—melanoma	0.00413	0.0076	CcSEcCtD
Montelukast—Neuropathy—Temozolomide—melanoma	0.00403	0.00742	CcSEcCtD
Montelukast—Injury—Bleomycin—melanoma	0.00402	0.0074	CcSEcCtD
Montelukast—Erythema multiforme—Vemurafenib—melanoma	0.00399	0.00734	CcSEcCtD
Montelukast—Cardiac disorder—Vemurafenib—melanoma	0.00391	0.0072	CcSEcCtD
Montelukast—Dermatitis atopic—Docetaxel—melanoma	0.00386	0.0071	CcSEcCtD
Montelukast—Mediastinal disorder—Vemurafenib—melanoma	0.0038	0.007	CcSEcCtD
Montelukast—Otitis media—Docetaxel—melanoma	0.00367	0.00675	CcSEcCtD
Montelukast—Ear pain—Temozolomide—melanoma	0.00365	0.00672	CcSEcCtD
Montelukast—Rhinorrhoea—Docetaxel—melanoma	0.00352	0.00648	CcSEcCtD
Montelukast—Gastroenteritis—Temozolomide—melanoma	0.00352	0.00647	CcSEcCtD
Montelukast—Injury—Carmustine—melanoma	0.00351	0.00646	CcSEcCtD
Montelukast—Thirst—Temozolomide—melanoma	0.00327	0.00603	CcSEcCtD
Montelukast—Cough—Vemurafenib—melanoma	0.0032	0.0059	CcSEcCtD
Montelukast—Bone disorder—Docetaxel—melanoma	0.00316	0.00582	CcSEcCtD
Montelukast—Arthralgia—Vemurafenib—melanoma	0.00313	0.00575	CcSEcCtD
Montelukast—Myalgia—Vemurafenib—melanoma	0.00313	0.00575	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.0031	0.00571	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.0031	0.00571	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.0031	0.00571	CcSEcCtD
Montelukast—Anaphylactic shock—Vemurafenib—melanoma	0.003	0.00551	CcSEcCtD
Montelukast—Infection—Vemurafenib—melanoma	0.00298	0.00548	CcSEcCtD
Montelukast—Nervous system disorder—Vemurafenib—melanoma	0.00294	0.00541	CcSEcCtD
Montelukast—Skin disorder—Vemurafenib—melanoma	0.00291	0.00536	CcSEcCtD
Montelukast—Pneumonia—Bleomycin—melanoma	0.00286	0.00527	CcSEcCtD
Montelukast—Hepatocellular injury—Docetaxel—melanoma	0.00285	0.00525	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Temozolomide—melanoma	0.00281	0.00516	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Temozolomide—melanoma	0.00281	0.00516	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Temozolomide—melanoma	0.00275	0.00506	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00273	0.00502	CcSEcCtD
Montelukast—Neuropathy—Docetaxel—melanoma	0.00268	0.00493	CcSEcCtD
Montelukast—Pneumonia—Dactinomycin—melanoma	0.00267	0.00491	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.00263	0.00484	CcSEcCtD
Montelukast—Bronchitis—Temozolomide—melanoma	0.00259	0.00477	CcSEcCtD
Montelukast—Gastrointestinal disorder—Vemurafenib—melanoma	0.00259	0.00476	CcSEcCtD
Montelukast—Fatigue—Vemurafenib—melanoma	0.00258	0.00475	CcSEcCtD
Montelukast—Hypoaesthesia—Bleomycin—melanoma	0.00254	0.00468	CcSEcCtD
Montelukast—Upper respiratory tract infection—Temozolomide—melanoma	0.0025	0.00461	CcSEcCtD
Montelukast—Pneumonia—Carmustine—melanoma	0.0025	0.0046	CcSEcCtD
Montelukast—Neuropathy peripheral—Carmustine—melanoma	0.00244	0.00448	CcSEcCtD
Montelukast—Pneumonia—Temozolomide—melanoma	0.00242	0.00444	CcSEcCtD
Montelukast—Infestation—Temozolomide—melanoma	0.0024	0.00442	CcSEcCtD
Montelukast—Infestation NOS—Temozolomide—melanoma	0.0024	0.00442	CcSEcCtD
Montelukast—Hepatitis—Dactinomycin—melanoma	0.00238	0.00439	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00238	0.00438	CcSEcCtD
Montelukast—Body temperature increased—Vemurafenib—melanoma	0.00237	0.00436	CcSEcCtD
Montelukast—Pharyngitis—Dactinomycin—melanoma	0.00237	0.00435	CcSEcCtD
Montelukast—Neuropathy peripheral—Temozolomide—melanoma	0.00235	0.00433	CcSEcCtD
Montelukast—Hepatobiliary disease—Temozolomide—melanoma	0.00227	0.00418	CcSEcCtD
Montelukast—Erythema multiforme—Dactinomycin—melanoma	0.00225	0.00415	CcSEcCtD
Montelukast—Sinusitis—Temozolomide—melanoma	0.00225	0.00415	CcSEcCtD
Montelukast—Hypoaesthesia—Carmustine—melanoma	0.00222	0.00408	CcSEcCtD
Montelukast—Hallucination—Carmustine—melanoma	0.00222	0.00408	CcSEcCtD
Montelukast—Hypersensitivity—Vemurafenib—melanoma	0.00221	0.00406	CcSEcCtD
Montelukast—Connective tissue disorder—Carmustine—melanoma	0.00219	0.00403	CcSEcCtD
Montelukast—Hepatitis—Temozolomide—melanoma	0.00216	0.00397	CcSEcCtD
Montelukast—Asthenia—Vemurafenib—melanoma	0.00215	0.00396	CcSEcCtD
Montelukast—Hypoaesthesia—Temozolomide—melanoma	0.00214	0.00395	CcSEcCtD
Montelukast—Hallucination—Temozolomide—melanoma	0.00214	0.00395	CcSEcCtD
Montelukast—Pharyngitis—Temozolomide—melanoma	0.00214	0.00394	CcSEcCtD
Montelukast—Urinary tract disorder—Temozolomide—melanoma	0.00213	0.00392	CcSEcCtD
Montelukast—Pruritus—Vemurafenib—melanoma	0.00212	0.0039	CcSEcCtD
Montelukast—Connective tissue disorder—Temozolomide—melanoma	0.00212	0.0039	CcSEcCtD
Montelukast—Urethral disorder—Temozolomide—melanoma	0.00211	0.00389	CcSEcCtD
Montelukast—Diarrhoea—Vemurafenib—melanoma	0.00205	0.00377	CcSEcCtD
Montelukast—Erythema multiforme—Temozolomide—melanoma	0.00204	0.00375	CcSEcCtD
Montelukast—Cardiac disorder—Temozolomide—melanoma	0.002	0.00368	CcSEcCtD
Montelukast—Dizziness—Vemurafenib—melanoma	0.00198	0.00365	CcSEcCtD
Montelukast—Mental disorder—Carmustine—melanoma	0.00195	0.0036	CcSEcCtD
Montelukast—Immune system disorder—Temozolomide—melanoma	0.00195	0.00358	CcSEcCtD
Montelukast—Mediastinal disorder—Temozolomide—melanoma	0.00194	0.00358	CcSEcCtD
Montelukast—Cough—Bleomycin—melanoma	0.00194	0.00357	CcSEcCtD
Montelukast—Vomiting—Vemurafenib—melanoma	0.00191	0.00351	CcSEcCtD
Montelukast—Myalgia—Bleomycin—melanoma	0.00189	0.00349	CcSEcCtD
Montelukast—Rash—Vemurafenib—melanoma	0.00189	0.00348	CcSEcCtD
Montelukast—Mental disorder—Temozolomide—melanoma	0.00189	0.00348	CcSEcCtD
Montelukast—Dermatitis—Vemurafenib—melanoma	0.00189	0.00347	CcSEcCtD
Montelukast—Headache—Vemurafenib—melanoma	0.00188	0.00345	CcSEcCtD
Montelukast—Cramp muscle—Docetaxel—melanoma	0.00187	0.00343	CcSEcCtD
Montelukast—Toxic epidermal necrolysis—Docetaxel—melanoma	0.00187	0.00343	CcSEcCtD
Montelukast—Aspartate aminotransferase increased—Docetaxel—melanoma	0.00187	0.00343	CcSEcCtD
Montelukast—Nasopharyngitis—Docetaxel—melanoma	0.00185	0.00341	CcSEcCtD
Montelukast—Alanine aminotransferase increased—Docetaxel—melanoma	0.00183	0.00336	CcSEcCtD
Montelukast—Tremor—Carmustine—melanoma	0.00182	0.00335	CcSEcCtD
Montelukast—Anaphylactic shock—Bleomycin—melanoma	0.00182	0.00334	CcSEcCtD
Montelukast—Oedema—Bleomycin—melanoma	0.00182	0.00334	CcSEcCtD
Montelukast—Infection—Bleomycin—melanoma	0.0018	0.00332	CcSEcCtD
Montelukast—Agitation—Carmustine—melanoma	0.00178	0.00328	CcSEcCtD
Montelukast—Nausea—Vemurafenib—melanoma	0.00178	0.00328	CcSEcCtD
Montelukast—Thrombocytopenia—Bleomycin—melanoma	0.00178	0.00327	CcSEcCtD
Montelukast—Myalgia—Dactinomycin—melanoma	0.00177	0.00325	CcSEcCtD
Montelukast—Tremor—Temozolomide—melanoma	0.00176	0.00324	CcSEcCtD
Montelukast—Agitation—Temozolomide—melanoma	0.00172	0.00317	CcSEcCtD
Montelukast—Angioedema—Temozolomide—melanoma	0.00171	0.00316	CcSEcCtD
Montelukast—Oedema—Dactinomycin—melanoma	0.00169	0.00312	CcSEcCtD
Montelukast—Convulsion—Carmustine—melanoma	0.00168	0.0031	CcSEcCtD
Montelukast—Infection—Dactinomycin—melanoma	0.00168	0.0031	CcSEcCtD
Montelukast—Palpitations—Temozolomide—melanoma	0.00166	0.00305	CcSEcCtD
Montelukast—Thrombocytopenia—Dactinomycin—melanoma	0.00166	0.00305	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Bleomycin—melanoma	0.00165	0.00304	CcSEcCtD
Montelukast—Myalgia—Carmustine—melanoma	0.00165	0.00304	CcSEcCtD
Montelukast—Anxiety—Carmustine—melanoma	0.00165	0.00303	CcSEcCtD
Montelukast—Cough—Temozolomide—melanoma	0.00164	0.00301	CcSEcCtD
Montelukast—Paraesthesia—Bleomycin—melanoma	0.00163	0.003	CcSEcCtD
Montelukast—Convulsion—Temozolomide—melanoma	0.00163	0.00299	CcSEcCtD
Montelukast—Pneumonia—Docetaxel—melanoma	0.00161	0.00296	CcSEcCtD
Montelukast—Arthralgia—Temozolomide—melanoma	0.0016	0.00294	CcSEcCtD
Montelukast—Myalgia—Temozolomide—melanoma	0.0016	0.00294	CcSEcCtD
Montelukast—Infestation NOS—Docetaxel—melanoma	0.0016	0.00294	CcSEcCtD
Montelukast—Infestation—Docetaxel—melanoma	0.0016	0.00294	CcSEcCtD
Montelukast—Anxiety—Temozolomide—melanoma	0.00159	0.00293	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00159	0.00292	CcSEcCtD
Montelukast—Oedema—Carmustine—melanoma	0.00158	0.00292	CcSEcCtD
Montelukast—Stevens-Johnson syndrome—Docetaxel—melanoma	0.00158	0.00291	CcSEcCtD
Montelukast—Infection—Carmustine—melanoma	0.00157	0.0029	CcSEcCtD
Montelukast—Neuropathy peripheral—Docetaxel—melanoma	0.00157	0.00288	CcSEcCtD
Montelukast—Jaundice—Docetaxel—melanoma	0.00156	0.00286	CcSEcCtD
Montelukast—Pain—Bleomycin—melanoma	0.00155	0.00286	CcSEcCtD
Montelukast—Conjunctivitis—Docetaxel—melanoma	0.00155	0.00286	CcSEcCtD
Montelukast—Thrombocytopenia—Carmustine—melanoma	0.00155	0.00286	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00154	0.00284	CcSEcCtD
Montelukast—Oedema—Temozolomide—melanoma	0.00153	0.00282	CcSEcCtD
Montelukast—Anaphylactic shock—Temozolomide—melanoma	0.00153	0.00282	CcSEcCtD
Montelukast—Infection—Temozolomide—melanoma	0.00152	0.0028	CcSEcCtD
Montelukast—Hepatobiliary disease—Docetaxel—melanoma	0.00151	0.00278	CcSEcCtD
Montelukast—Epistaxis—Docetaxel—melanoma	0.00151	0.00277	CcSEcCtD
Montelukast—Nervous system disorder—Temozolomide—melanoma	0.0015	0.00276	CcSEcCtD
Montelukast—Thrombocytopenia—Temozolomide—melanoma	0.0015	0.00276	CcSEcCtD
Montelukast—Skin disorder—Temozolomide—melanoma	0.00149	0.00274	CcSEcCtD
Montelukast—Fatigue—Dactinomycin—melanoma	0.00146	0.00269	CcSEcCtD
Montelukast—Pain—Dactinomycin—melanoma	0.00145	0.00266	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Carmustine—melanoma	0.00144	0.00266	CcSEcCtD
Montelukast—Urticaria—Bleomycin—melanoma	0.00144	0.00265	CcSEcCtD
Montelukast—Rhinitis—Docetaxel—melanoma	0.00144	0.00264	CcSEcCtD
Montelukast—Body temperature increased—Bleomycin—melanoma	0.00144	0.00264	CcSEcCtD
Montelukast—Hepatitis—Docetaxel—melanoma	0.00143	0.00264	CcSEcCtD
Montelukast—Insomnia—Carmustine—melanoma	0.00143	0.00264	CcSEcCtD
Montelukast—Hypoaesthesia—Docetaxel—melanoma	0.00143	0.00262	CcSEcCtD
Montelukast—Paraesthesia—Carmustine—melanoma	0.00142	0.00262	CcSEcCtD
Montelukast—Pharyngitis—Docetaxel—melanoma	0.00142	0.00262	CcSEcCtD
Montelukast—Urinary tract disorder—Docetaxel—melanoma	0.00142	0.00261	CcSEcCtD
Montelukast—Somnolence—Carmustine—melanoma	0.00141	0.00259	CcSEcCtD
Montelukast—Connective tissue disorder—Docetaxel—melanoma	0.00141	0.00259	CcSEcCtD
Montelukast—Urethral disorder—Docetaxel—melanoma	0.00141	0.00259	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Temozolomide—melanoma	0.0014	0.00257	CcSEcCtD
Montelukast—Insomnia—Temozolomide—melanoma	0.00139	0.00255	CcSEcCtD
Montelukast—Gastrointestinal pain—Dactinomycin—melanoma	0.00138	0.00255	CcSEcCtD
Montelukast—Paraesthesia—Temozolomide—melanoma	0.00138	0.00253	CcSEcCtD
Montelukast—Gastrointestinal disorder—Carmustine—melanoma	0.00137	0.00252	CcSEcCtD
Montelukast—Somnolence—Temozolomide—melanoma	0.00136	0.00251	CcSEcCtD
Montelukast—Erythema multiforme—Docetaxel—melanoma	0.00136	0.00249	CcSEcCtD
Montelukast—Pain—Carmustine—melanoma	0.00136	0.00249	CcSEcCtD
Montelukast—Dyspepsia—Temozolomide—melanoma	0.00135	0.00248	CcSEcCtD
Montelukast—Abdominal pain—Dactinomycin—melanoma	0.00134	0.00246	CcSEcCtD
Montelukast—Body temperature increased—Dactinomycin—melanoma	0.00134	0.00246	CcSEcCtD
Montelukast—Hypersensitivity—Bleomycin—melanoma	0.00134	0.00246	CcSEcCtD
Montelukast—Cardiac disorder—Docetaxel—melanoma	0.00133	0.00245	CcSEcCtD
Montelukast—Gastrointestinal disorder—Temozolomide—melanoma	0.00132	0.00243	CcSEcCtD
Montelukast—Fatigue—Temozolomide—melanoma	0.00132	0.00243	CcSEcCtD
Montelukast—Pain—Temozolomide—melanoma	0.00131	0.00241	CcSEcCtD
Montelukast—Asthenia—Bleomycin—melanoma	0.0013	0.0024	CcSEcCtD
Montelukast—Gastrointestinal pain—Carmustine—melanoma	0.0013	0.00238	CcSEcCtD
Montelukast—Immune system disorder—Docetaxel—melanoma	0.00129	0.00238	CcSEcCtD
Montelukast—Mediastinal disorder—Docetaxel—melanoma	0.00129	0.00238	CcSEcCtD
Montelukast—Pruritus—Bleomycin—melanoma	0.00128	0.00236	CcSEcCtD
Montelukast—Mental disorder—Docetaxel—melanoma	0.00126	0.00231	CcSEcCtD
Montelukast—Abdominal pain—Carmustine—melanoma	0.00125	0.00231	CcSEcCtD
Montelukast—Body temperature increased—Carmustine—melanoma	0.00125	0.00231	CcSEcCtD
Montelukast—Gastrointestinal pain—Temozolomide—melanoma	0.00125	0.0023	CcSEcCtD
Montelukast—Hypersensitivity—Dactinomycin—melanoma	0.00125	0.0023	CcSEcCtD
Montelukast—Urticaria—Temozolomide—melanoma	0.00122	0.00224	CcSEcCtD
Montelukast—Asthenia—Dactinomycin—melanoma	0.00121	0.00224	CcSEcCtD
Montelukast—Abdominal pain—Temozolomide—melanoma	0.00121	0.00223	CcSEcCtD
Montelukast—Body temperature increased—Temozolomide—melanoma	0.00121	0.00223	CcSEcCtD
Montelukast—Muscle spasms—Docetaxel—melanoma	0.0012	0.00221	CcSEcCtD
Montelukast—Hypersensitivity—Carmustine—melanoma	0.00117	0.00215	CcSEcCtD
Montelukast—Diarrhoea—Dactinomycin—melanoma	0.00116	0.00213	CcSEcCtD
Montelukast—Vomiting—Bleomycin—melanoma	0.00115	0.00212	CcSEcCtD
Montelukast—Rash—Bleomycin—melanoma	0.00114	0.00211	CcSEcCtD
Montelukast—Dermatitis—Bleomycin—melanoma	0.00114	0.0021	CcSEcCtD
Montelukast—Asthenia—Carmustine—melanoma	0.00114	0.00209	CcSEcCtD
Montelukast—Hypersensitivity—Temozolomide—melanoma	0.00113	0.00208	CcSEcCtD
Montelukast—Palpitations—Docetaxel—melanoma	0.0011	0.00203	CcSEcCtD
Montelukast—Asthenia—Temozolomide—melanoma	0.0011	0.00202	CcSEcCtD
Montelukast—Cough—Docetaxel—melanoma	0.00109	0.002	CcSEcCtD
Montelukast—Diarrhoea—Carmustine—melanoma	0.00108	0.002	CcSEcCtD
Montelukast—Pruritus—Temozolomide—melanoma	0.00108	0.00199	CcSEcCtD
Montelukast—Convulsion—Docetaxel—melanoma	0.00108	0.00199	CcSEcCtD
Montelukast—Nausea—Bleomycin—melanoma	0.00108	0.00198	CcSEcCtD
Montelukast—Vomiting—Dactinomycin—melanoma	0.00108	0.00198	CcSEcCtD
Montelukast—Rash—Dactinomycin—melanoma	0.00107	0.00196	CcSEcCtD
Montelukast—Myalgia—Docetaxel—melanoma	0.00106	0.00196	CcSEcCtD
Montelukast—Arthralgia—Docetaxel—melanoma	0.00106	0.00196	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00106	0.00194	CcSEcCtD
Montelukast—Dizziness—Carmustine—melanoma	0.00105	0.00193	CcSEcCtD
Montelukast—Diarrhoea—Temozolomide—melanoma	0.00105	0.00193	CcSEcCtD
Montelukast—Anaphylactic shock—Docetaxel—melanoma	0.00102	0.00187	CcSEcCtD
Montelukast—Oedema—Docetaxel—melanoma	0.00102	0.00187	CcSEcCtD
Montelukast—Dizziness—Temozolomide—melanoma	0.00101	0.00186	CcSEcCtD
Montelukast—Infection—Docetaxel—melanoma	0.00101	0.00186	CcSEcCtD
Montelukast—Vomiting—Carmustine—melanoma	0.00101	0.00185	CcSEcCtD
Montelukast—Nausea—Dactinomycin—melanoma	0.00101	0.00185	CcSEcCtD
Montelukast—Rash—Carmustine—melanoma	0.000999	0.00184	CcSEcCtD
Montelukast—Nervous system disorder—Docetaxel—melanoma	0.000999	0.00184	CcSEcCtD
Montelukast—Dermatitis—Carmustine—melanoma	0.000998	0.00184	CcSEcCtD
Montelukast—Thrombocytopenia—Docetaxel—melanoma	0.000997	0.00184	CcSEcCtD
Montelukast—Headache—Carmustine—melanoma	0.000993	0.00183	CcSEcCtD
Montelukast—Skin disorder—Docetaxel—melanoma	0.000989	0.00182	CcSEcCtD
Montelukast—Vomiting—Temozolomide—melanoma	0.000974	0.00179	CcSEcCtD
Montelukast—Rash—Temozolomide—melanoma	0.000966	0.00178	CcSEcCtD
Montelukast—Dermatitis—Temozolomide—melanoma	0.000965	0.00178	CcSEcCtD
Montelukast—Headache—Temozolomide—melanoma	0.000959	0.00177	CcSEcCtD
Montelukast—Nausea—Carmustine—melanoma	0.000941	0.00173	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Docetaxel—melanoma	0.000928	0.00171	CcSEcCtD
Montelukast—Insomnia—Docetaxel—melanoma	0.000921	0.0017	CcSEcCtD
Montelukast—Paraesthesia—Docetaxel—melanoma	0.000914	0.00168	CcSEcCtD
Montelukast—Nausea—Temozolomide—melanoma	0.00091	0.00167	CcSEcCtD
Montelukast—Somnolence—Docetaxel—melanoma	0.000905	0.00167	CcSEcCtD
Montelukast—Dyspepsia—Docetaxel—melanoma	0.000896	0.00165	CcSEcCtD
Montelukast—Gastrointestinal disorder—Docetaxel—melanoma	0.000879	0.00162	CcSEcCtD
Montelukast—Fatigue—Docetaxel—melanoma	0.000878	0.00162	CcSEcCtD
Montelukast—Pain—Docetaxel—melanoma	0.000871	0.0016	CcSEcCtD
Montelukast—Gastrointestinal pain—Docetaxel—melanoma	0.000833	0.00153	CcSEcCtD
Montelukast—Abdominal pain—Docetaxel—melanoma	0.000805	0.00148	CcSEcCtD
Montelukast—Body temperature increased—Docetaxel—melanoma	0.000805	0.00148	CcSEcCtD
Montelukast—Hypersensitivity—Docetaxel—melanoma	0.00075	0.00138	CcSEcCtD
Montelukast—Asthenia—Docetaxel—melanoma	0.000731	0.00134	CcSEcCtD
Montelukast—Pruritus—Docetaxel—melanoma	0.000721	0.00133	CcSEcCtD
Montelukast—Diarrhoea—Docetaxel—melanoma	0.000697	0.00128	CcSEcCtD
Montelukast—Dizziness—Docetaxel—melanoma	0.000673	0.00124	CcSEcCtD
Montelukast—Vomiting—Docetaxel—melanoma	0.000648	0.00119	CcSEcCtD
Montelukast—Rash—Docetaxel—melanoma	0.000642	0.00118	CcSEcCtD
Montelukast—Dermatitis—Docetaxel—melanoma	0.000642	0.00118	CcSEcCtD
Montelukast—Headache—Docetaxel—melanoma	0.000638	0.00117	CcSEcCtD
Montelukast—Nausea—Docetaxel—melanoma	0.000605	0.00111	CcSEcCtD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.000132	0.00041	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—SPP1—melanoma	0.000132	0.00041	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GPAM—melanoma	0.000132	0.000408	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MAP2K2—melanoma	0.000132	0.000408	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—CXCL8—melanoma	0.000131	0.000408	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—SDHD—melanoma	0.000129	0.000399	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—BSG—melanoma	0.000129	0.000399	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CSPG4—melanoma	0.000129	0.000399	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—IL2—melanoma	0.000126	0.00039	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TERT—melanoma	0.000125	0.000388	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—RAC1—melanoma	0.000125	0.000387	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PRKCA—melanoma	0.000125	0.000387	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GPAM—melanoma	0.000125	0.000386	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—HS3ST5—melanoma	0.000124	0.000386	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—ERCC2—melanoma	0.000124	0.000384	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.000123	0.000382	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—HIF1A—melanoma	0.00012	0.000371	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PLCB4—melanoma	0.000116	0.000359	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—KDR—melanoma	0.000114	0.000355	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—FASN—melanoma	0.000114	0.000353	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PLA2G6—melanoma	0.000112	0.000347	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—FN1—melanoma	0.00011	0.000342	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—SLC6A11—melanoma	0.000109	0.000338	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PIP4K2A—melanoma	0.000109	0.000338	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NOTCH1—melanoma	0.000108	0.000335	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—MTAP—melanoma	0.000106	0.000329	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PLA2G6—melanoma	0.000106	0.000328	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CD80—melanoma	0.000106	0.000328	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—APC—melanoma	0.000105	0.000327	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PIK3CG—melanoma	0.000105	0.000327	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—KIT—melanoma	0.000105	0.000327	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—NRAS—melanoma	0.000105	0.000327	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—EGF—melanoma	0.000104	0.000323	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.000104	0.000321	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	0.000103	0.000318	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—MAPK3—melanoma	0.000101	0.000313	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—VCAN—melanoma	0.000101	0.000312	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.0001	0.000311	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—BRAF—melanoma	9.91e-05	0.000307	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PIK3CG—melanoma	9.78e-05	0.000303	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IGF1—melanoma	9.66e-05	0.0003	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ACER3—melanoma	9.65e-05	0.000299	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—MAPK1—melanoma	9.61e-05	0.000298	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—EGFR—melanoma	9.61e-05	0.000298	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	9.52e-05	0.000295	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—VCAN—melanoma	9.51e-05	0.000295	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PHGDH—melanoma	9.45e-05	0.000293	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—LUM—melanoma	9.45e-05	0.000293	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PPARG—melanoma	9.44e-05	0.000293	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PLCB4—melanoma	9.43e-05	0.000292	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MAP2K1—melanoma	9.33e-05	0.000289	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PIK3CD—melanoma	9.27e-05	0.000288	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—HPSE—melanoma	9.26e-05	0.000287	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	9.26e-05	0.000287	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PPARG—melanoma	9.19e-05	0.000285	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—PIK3CA—melanoma	9.18e-05	0.000285	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CUBN—melanoma	9.09e-05	0.000282	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—KRAS—melanoma	9.08e-05	0.000282	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—FGF2—melanoma	8.88e-05	0.000275	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PIP4K2A—melanoma	8.87e-05	0.000275	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—SLC6A11—melanoma	8.87e-05	0.000275	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—UGT2B10—melanoma	8.83e-05	0.000274	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—BSG—melanoma	8.78e-05	0.000272	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—SDHD—melanoma	8.78e-05	0.000272	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CSPG4—melanoma	8.78e-05	0.000272	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—MTAP—melanoma	8.62e-05	0.000267	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PIK3CD—melanoma	8.59e-05	0.000267	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GPAM—melanoma	8.5e-05	0.000264	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—ALB—melanoma	8.48e-05	0.000263	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CYP17A1—melanoma	8.48e-05	0.000263	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	8.43e-05	0.000261	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	8.37e-05	0.00026	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—PIK3CA—melanoma	8.34e-05	0.000259	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MDM2—melanoma	8.31e-05	0.000258	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—ALB—melanoma	8.26e-05	0.000256	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—HS3ST5—melanoma	8.21e-05	0.000255	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—ERBB2—melanoma	8.19e-05	0.000254	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PIK3CB—melanoma	8.08e-05	0.000251	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CYP17A1—melanoma	8.02e-05	0.000249	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GNA11—melanoma	8.01e-05	0.000248	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—FASN—melanoma	7.84e-05	0.000243	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CXCL8—melanoma	7.77e-05	0.000241	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—HRAS—melanoma	7.72e-05	0.000239	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—SLC5A5—melanoma	7.71e-05	0.000239	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—LUM—melanoma	7.69e-05	0.000238	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PHGDH—melanoma	7.69e-05	0.000238	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CDKN1B—melanoma	7.58e-05	0.000235	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GNA11—melanoma	7.58e-05	0.000235	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—HPSE—melanoma	7.54e-05	0.000234	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—AKT1—melanoma	7.5e-05	0.000233	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PIK3CB—melanoma	7.49e-05	0.000232	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CD44—melanoma	7.45e-05	0.000231	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GNAQ—melanoma	7.45e-05	0.000231	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CASP3—melanoma	7.43e-05	0.000231	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PTGS2—melanoma	7.42e-05	0.00023	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IL2—melanoma	7.42e-05	0.00023	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—FASN—melanoma	7.41e-05	0.00023	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CUBN—melanoma	7.4e-05	0.000229	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—IL6—melanoma	7.39e-05	0.000229	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.29e-05	0.000226	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—SLC5A5—melanoma	7.29e-05	0.000226	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CCND1—melanoma	7.24e-05	0.000224	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PLA2G6—melanoma	7.23e-05	0.000224	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.23e-05	0.000224	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CTNNB1—melanoma	7.17e-05	0.000222	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—BSG—melanoma	7.15e-05	0.000222	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CSPG4—melanoma	7.15e-05	0.000222	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—SDHD—melanoma	7.15e-05	0.000222	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CYP1B1—melanoma	7.14e-05	0.000221	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GNAQ—melanoma	7.04e-05	0.000218	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CD44—melanoma	7.04e-05	0.000218	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MMP9—melanoma	7.02e-05	0.000218	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CDKN1A—melanoma	7e-05	0.000217	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PTEN—melanoma	6.98e-05	0.000217	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NFKB1—melanoma	6.95e-05	0.000216	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GPAM—melanoma	6.92e-05	0.000215	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—AKT1—melanoma	6.81e-05	0.000211	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CYP1B1—melanoma	6.75e-05	0.000209	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—VCAN—melanoma	6.5e-05	0.000201	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PTEN—melanoma	6.47e-05	0.000201	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—VEGFA—melanoma	6.31e-05	0.000196	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.3e-05	0.000195	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—STAT3—melanoma	6.25e-05	0.000194	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NRAS—melanoma	6.23e-05	0.000193	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PLCB4—melanoma	6.22e-05	0.000193	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	6.15e-05	0.000191	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MAPK3—melanoma	5.97e-05	0.000185	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	5.93e-05	0.000184	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PLA2G6—melanoma	5.89e-05	0.000183	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ABCB1—melanoma	5.88e-05	0.000182	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SLC6A11—melanoma	5.85e-05	0.000181	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PIP4K2A—melanoma	5.85e-05	0.000181	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MYC—melanoma	5.8e-05	0.00018	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—MTAP—melanoma	5.69e-05	0.000176	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MAPK1—melanoma	5.68e-05	0.000176	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—EGFR—melanoma	5.68e-05	0.000176	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ABCB1—melanoma	5.56e-05	0.000172	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP17A1—melanoma	5.48e-05	0.00017	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PRKCA—melanoma	5.41e-05	0.000168	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	5.41e-05	0.000168	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ERCC2—melanoma	5.37e-05	0.000166	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—KRAS—melanoma	5.36e-05	0.000166	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	5.34e-05	0.000165	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—VCAN—melanoma	5.29e-05	0.000164	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GNA11—melanoma	5.18e-05	0.000161	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PRKCA—melanoma	5.12e-05	0.000159	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ERCC2—melanoma	5.08e-05	0.000157	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—LUM—melanoma	5.07e-05	0.000157	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PHGDH—melanoma	5.07e-05	0.000157	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—FASN—melanoma	5.06e-05	0.000157	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	5e-05	0.000155	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—SLC5A5—melanoma	4.98e-05	0.000155	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—HPSE—melanoma	4.97e-05	0.000154	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PIK3CA—melanoma	4.93e-05	0.000153	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CUBN—melanoma	4.88e-05	0.000151	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	4.83e-05	0.00015	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GNAQ—melanoma	4.81e-05	0.000149	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CD44—melanoma	4.81e-05	0.000149	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TP53—melanoma	4.77e-05	0.000148	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SDHD—melanoma	4.71e-05	0.000146	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—BSG—melanoma	4.71e-05	0.000146	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CSPG4—melanoma	4.71e-05	0.000146	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	4.71e-05	0.000146	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	4.67e-05	0.000145	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP1B1—melanoma	4.61e-05	0.000143	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PIK3CA—melanoma	4.57e-05	0.000142	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GPAM—melanoma	4.56e-05	0.000142	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—HRAS—melanoma	4.56e-05	0.000141	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP17A1—melanoma	4.46e-05	0.000138	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.45e-05	0.000138	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	4.4e-05	0.000136	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IL6—melanoma	4.36e-05	0.000135	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	4.34e-05	0.000135	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PIK3CG—melanoma	4.24e-05	0.000131	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GNA11—melanoma	4.21e-05	0.000131	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—FASN—melanoma	4.12e-05	0.000128	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PPARG—melanoma	4.09e-05	0.000127	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.07e-05	0.000126	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—SLC5A5—melanoma	4.05e-05	0.000126	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—AKT1—melanoma	4.02e-05	0.000125	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PIK3CG—melanoma	4.01e-05	0.000124	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GNAQ—melanoma	3.92e-05	0.000121	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CD44—melanoma	3.92e-05	0.000121	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PLA2G6—melanoma	3.88e-05	0.00012	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PPARG—melanoma	3.87e-05	0.00012	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.83e-05	0.000119	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.8e-05	0.000118	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ABCB1—melanoma	3.8e-05	0.000118	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP1B1—melanoma	3.75e-05	0.000116	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—AKT1—melanoma	3.73e-05	0.000116	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PIK3CD—melanoma	3.73e-05	0.000116	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ALB—melanoma	3.68e-05	0.000114	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PIK3CD—melanoma	3.52e-05	0.000109	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PRKCA—melanoma	3.5e-05	0.000108	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—VCAN—melanoma	3.49e-05	0.000108	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ALB—melanoma	3.48e-05	0.000108	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ERCC2—melanoma	3.47e-05	0.000108	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.31e-05	0.000103	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PIK3CB—melanoma	3.25e-05	0.000101	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PTGS2—melanoma	3.22e-05	9.98e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ABCB1—melanoma	3.09e-05	9.59e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PIK3CB—melanoma	3.07e-05	9.53e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PTGS2—melanoma	3.04e-05	9.44e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP17A1—melanoma	2.94e-05	9.12e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.87e-05	8.91e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PRKCA—melanoma	2.85e-05	8.82e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ERCC2—melanoma	2.82e-05	8.75e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PTEN—melanoma	2.81e-05	8.71e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GNA11—melanoma	2.78e-05	8.62e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PIK3CG—melanoma	2.74e-05	8.49e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—FASN—melanoma	2.72e-05	8.43e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SLC5A5—melanoma	2.67e-05	8.29e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PTEN—melanoma	2.65e-05	8.23e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PPARG—melanoma	2.64e-05	8.2e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GNAQ—melanoma	2.58e-05	8.01e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CD44—melanoma	2.58e-05	8.01e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP1B1—melanoma	2.48e-05	7.68e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PIK3CD—melanoma	2.41e-05	7.47e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ALB—melanoma	2.38e-05	7.37e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.34e-05	7.25e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PIK3CG—melanoma	2.23e-05	6.91e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PPARG—melanoma	2.15e-05	6.67e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PIK3CB—melanoma	2.1e-05	6.51e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PTGS2—melanoma	2.08e-05	6.45e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ABCB1—melanoma	2.04e-05	6.32e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PIK3CA—melanoma	1.98e-05	6.14e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PIK3CD—melanoma	1.96e-05	6.08e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ALB—melanoma	1.93e-05	6e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PRKCA—melanoma	1.88e-05	5.82e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PIK3CA—melanoma	1.87e-05	5.81e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ERCC2—melanoma	1.86e-05	5.77e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PTEN—melanoma	1.81e-05	5.62e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PIK3CB—melanoma	1.71e-05	5.3e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PTGS2—melanoma	1.69e-05	5.25e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—AKT1—melanoma	1.62e-05	5.02e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—AKT1—melanoma	1.53e-05	4.74e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PTEN—melanoma	1.48e-05	4.58e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PIK3CG—melanoma	1.47e-05	4.56e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PPARG—melanoma	1.42e-05	4.4e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PIK3CD—melanoma	1.29e-05	4.01e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PIK3CA—melanoma	1.28e-05	3.97e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ALB—melanoma	1.28e-05	3.96e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PIK3CB—melanoma	1.13e-05	3.49e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PTGS2—melanoma	1.12e-05	3.46e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—AKT1—melanoma	1.04e-05	3.24e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PIK3CA—melanoma	1.04e-05	3.23e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PTEN—melanoma	9.73e-06	3.02e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—AKT1—melanoma	8.5e-06	2.64e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PIK3CA—melanoma	6.87e-06	2.13e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—AKT1—melanoma	5.61e-06	1.74e-05	CbGpPWpGaD
